Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment

Abstract

The studies suggest that use of both the TH-NMYC model of neuroblastoma and the orthotopic xenograft model provide the optimal combination for testing new chemotherapies for this devastating childhood cancer.